The relationship between the placebo effect and spontaneous improvement in research on antidepressants: Are placebos really powerless?;Forholdet mellem placebovirkning og spontan bedring i antidepressive forsøg: Er placebo kraftesløs?

Ugeskrift for Laeger

Volumn 167, Issue 32, 2005, Pages 2865-2869

  Hougaard, Esben ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COCHRANE LIBRARY; FOOD AND DRUG ADMINISTRATION; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; OUTPATIENT; PSYCHOTHERAPY; PSYCINFO; REMISSION; REVIEW; SYSTEMATIC REVIEW; DEPRESSION; EVIDENCE BASED MEDICINE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS; PLACEBO EFFECT; REMISSION, SPONTANEOUS;

EID: 23844462840     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-602.
2. Depression Guideline Panel. Depression in primary care: Treatment of major depression. Vol. 2. Rockville, Maryland, U.S.: Department of Health and Human Services, Public Health Service. Agency for Health Care Policy and Research, 1993. Publ. no. 93-0551.
3. Walsh BT, Seidman SN, Sysko R et al. Placebo response in studies of major depression: Variable, substantial and growing. JAMA 2002;287:1840-7.
4. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Arch Gen Psychiat 2000;57:311-7.
5. Kirsch I, Moore TJ, Scoboria A et al. The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prev Treat 2002;5: article 23.
6. Storosum JG, Elferink AJA, van Zwieten BJ et al. Short-term efficacy of tricyclic antidepressants revisited: A meta-analytic study. Europ Neuropsychopharm 2001;11:173-80.
7. Khan A, Leventhal RM, Khan SR et al. Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administrations database. J Clin Psychopharm 2002;22:40-5.
8. Klerman GL, DiMascio A, Weissman M et al. Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-91.
9. Nandi DN, Ajmany S, Ganguli H et al. A clinical evaluation of depressives found in a rural survey in India. Brit J Psychiatry 1976;128:523-7.
10. Fuchs CZ, Rehm LP. A self-control behavior therapy program for depression. J Cons Clin Psychol 1977;45:206-15.
11. Rabkin JG, McGrath PJ, Qitkin FM et al. Effect of pill-giving on maintenance of placebo response in patients with chronic mild depression. Am J Psychiatry 1990;147:1622-6.
12. Frank E, Kupfer DJ, Perel JM et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093-9.
13. Lambert MJ, Bergin AE. The effectiveness of psychotherapy. I: Bergin AE, Garfield SL, eds. Handbook of psychotherapy and behavior change. 4. ed. New York: Wiley, 1994;143-189.
14. Spijker J, De Graff, R, Bijl RV et al. Duration of major depressive episodes in the general populations: Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Brit J Psychiatry 2002;181:208-13.
15. Storosum JG, Efferink AJA, van Zwieten BJ et al. Natural course and placebo response in short-term, placebo-controlled studies in major depression: A meta-analysis of published and non-published studies. Pharmacopsychiatry 2004;37:32-6.
16. Kirsch I. Changing expectations: a key to effective psychotherapy. Pacific Grove, Californien: Brooks/Cole, 1990.
17. Posternak MA, Miller I. Untreated short-term course of major depression: A meta-analysis of outcomes from studies using wait-list control groups. J Affect Disord 2001;66:139-46.
18. Kirsch I, Sapirstein G. Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prev Treat 1998;1: article 0002a.
19. Craighead WE, Hart AB, Craighead LW, Mardi SS. Psychosocial treatments for major depressive disorder. I: Nathan PE, Gorman JM, eds. A guide to treatments that work. 2. ed. New York: Oxford University Press, 2002; 245-61.
20. Hougaard E, Nielsen T. Forholdet mellem psykologisk og medicinsk behandling af depression, I: Bechgaard B, Jensen HH, Nielsen T, eds. Forholdet mellem psykologisk og medicinsk behandling af psykiske lidelser. København: Reitzels Forlag, 2001;94-142.
21. Hougaard E. Psykoterapi: Teori ogforskning. 2. ed. København: Dansk Psykologisk Forlag, 2004.
22. Elkin I, Shea T, Watkins JT et al. National Institute of Mental Health treatment of depression collaborative research program. General effectiveness of treatments. Arch Gen Psychiatry 1989;46:971-82.
23. Sotsky SM, Glass DR, Shea MT et al. Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1991;148:997-1008.
24. Hougaard E, Nielsen T, Zachariae B. Placebovirkningen i medicinsk behandling af depression. Ugeskr Læger 1999;162:2314-7.
25. Moncrieff J, Wessely S, Hardy R. Active placebo versus antidepressants for depression. Cochrane Database Syst rev 2001;(2):CD003012.
26. Greenberg RP, Bornstein RF, Zborowski MJ et al. A meta-analysis of fluoxetine outcome in the treatment of depression. J Ner Ment Dis 1993;182, 547-551.
27. Shapiro AK, Struening EL, Shapiro E et al. Diazepam: how much better than placebo? J Psychiatric Res 1983;17:51-73.
28. Blatt SJ, Zuroff DC, Quinlan DM et al. Interpersonal factors in brief treatment of depression: Further analyses of the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Cons Clin Psychol 1996;66:162-71.
29. Krupnick JL, Sotsky SM, Simmens S et al. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Cons Clin Psychol 1996;64:532-9.
30. Weiss M, Gaston L, Propst A et al. The role of the alliance in the pharmacologic treatment of depression. J Clin Psychiatry 1997;58:196-204.
31. Blatt SJ, Sanislow CA, Zuroff DC et al. Characteristics of effective therapists: Further analyses of data from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Cons Clin Psychol 1996;64:1276-84.
32. Norcross JC, ed. Psychotherapy relationships that work: therapist contributions and responsiveness to patients. New York: Oxford University Press, 2002.
33. Bower P, Rowland N, Mellor C et al. Effectiveness and cost effectiveness of counselling in primary care. Cochrane Dababase Syst Rev 2002 (1):CD00125.
34. Claësson MH. Er placebo virkelig powerless? Ugeskr Læger 2004;167:2147-9.
35. Vase L, Riley JL, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002;99:443-52.
36. Klein DN, Schwartz JE, Santiago NJ et al. Therapeutic alliance in depression treatment: Controlling for prior change and patient characteristics. J Cons Clin Psychol 2003;71:997-1006.
37. Rawlinson MC. Thruth-telling and paternalism in the clinic: philosophical reflections on the use of placebos in medical practice. I: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research, and mechanisms. New York: Guilford, 1985;403-16.
38. Shapiro AK, Morris LA. Placebo effects in medical and psychological therapies. I: Garfield SL, Bergin AE, eds. Handbook of psychotherapy and behavior change: an empirical analysis. 2. ed. New York: Wiley & Sons, 1978;369-409.
39. Andrews G. Placebo response in depression: bane of research, boon to therapy. Brit J Psychiatry 2001;178:192-4.